A new model of pharmacovigilance? A pilot study.

Zancan, A; Locatelli, C; Ramella, F; Tatoni, P; Bacis, G; Vecchio, S; Manzo, L

Zancan, A; Locatelli, C; Ramella, F; Tatoni, P; Bacis, G; Vecchio, S; Manzo, L.

Affiliation

Zancan A; Fondazione Maugeri IRCCS, Pavia, Italy. azancan@fsm.it

Biomed Pharmacother ; 63(6): 451-5, 2009 Jul.

Article in En | MEDLINE | ID: mdl-18790597

Subject(s)

Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Pharmacoepidemiology/methods; Adult; Aged; Aged, 80 and over; Anticoagulants/adverse effects; Antihypertensive Agents/adverse effects; Aspirin/adverse effects; Data Collection; Female; Hemorrhage/chemically induced; Humans; Male; Middle Aged; Pilot Projects; Telephone

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Adverse Drug Reaction Reporting Systems / Pharmacoepidemiology Type of study: Clinical_trials / Qualitative_research Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Biomed Pharmacother Year: 2009 Document type: Article Affiliation country: Italy Country of publication: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google